Orphanet Journal of Rare Diseases· 2026Q1
Phenotypic spectrum and diagnostic evolution in GLUT1 deficiency syndrome: a single-centre adult cohort experience
- 0citations
- Q1SCImago
- 2026year
Short summary
Adults with GLUT1 deficiency syndrome (GLUT1-DS) present with a wide range of symptoms and a median diagnostic delay of 6.5 years, with genetic testing, particularly WGS, identifying milder and atypical cases.
AI-generated from the title and abstract; the full text is not read.
Key points
- 31 adult patients with GLUT1-DS had a median age of 27 years and symptom onset at a median of 3 years.
- Median diagnostic delay was 6.5 years, with a maximum of 47 years.
- 56% were diagnosed via genetic testing, with a trend towards WGS in recent cases.
- Mixed phenotypes (seizure/movement) had the shortest diagnostic delay (3.5 years), while movement-predominant phenotypes had the longest (10 years).
- Loss-of-function variants correlated with earlier onset and seizure-predominant phenotypes, while missense variants were linked to later onset and movement disorders.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Background Glucose transporter type 1 deficiency syndrome (GLUT1-DS) is a rare neurometabolic disorder caused by pathogenic variants in the SLC2A1 gene. It is classically described as an infantile-onset condition; however, an expanding phenotypic spectrum is increasingly recognised, including diagnoses in adulthood. In this retrospective review of an adult cohort with GLUT1-DS, we explore the phenotypic diversity and diagnostic evolution within this cohort. Methods This retrospective case series was a single-centre study conducted at one metabolic centre and included adult patients with confirmed clinical, biochemical or genetic GLUT1-DS. Results Thirty-one individuals were identified with a median age of 27 years (IQR: 22–37). Median age at symptom onset was 3 years (IQR: 0–7). Median diagnostic delay was 6.5 years (IQR: 0.75–27.25) with a maximal delay of 47 years. 56% of individuals were diagnosed via genetic testing, most commonly by targeted single gene sequencing, with a shift towards exome and whole genome sequencing (WGS) in more recent cases. Individuals with a mixed phenotype (seizure and movement disorder) had the lowest median diagnostic delay (3.5 years, IQR: 1–13). The longest diagnostic delay was seen in movement-disorder predominant phenotypes (10 years, IQR: 2.5–37). Loss-of-function SLC2A1 variants tended to present earlier and with seizure-predominant or mixed phenotypes, whereas missense variants more commonly presented later with movement disorder-predominant phenotypes. Conclusion This case series demonstrates the marked phenotypic heterogeneity in GLUT1-DS. It also charts the evolution in diagnostic methods over the last few decades, illustrating how the increased availability of WGS and cascade testing has identified milder and atypical phenotypes. Widespread adoption of cascade testing would help identify individuals with undiagnosed GLUT1-DS and further define the full spectrum of GLUT1 deficiency.
The authors' abstract, as published at the source. Orphanet Journal of Rare Diseases, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Clinical Biochemistry
Clinical BiochemistryBiochemistry, Genetics and Molecular Biology